Estie Mermelstein, MSN, FNP-BC

Estie Mermelstein, MSN, FNP-BC, earned her Master of Science in nursing from Columbia University School of Nursing. She has worked as a nurse in women’s health and as a nurse practitioner in family medicine. Estie also earned a Bachelor of Arts in journalism and was editor-in-chief of her undergraduate newspaper. She currently freelances in medical communications with a focus on clinician-facing content. She and her husband have three young children and live in New Jersey.

All articles by Estie Mermelstein, MSN, FNP-BC

General Pulmonology

At the Intersection of 2 Pandemics: The Impact of COVID-19 on HIV

Estie Mermelstein, MSN, FNP-BC

July 15, 2021

A body of emerging research is attempting to quantify changes occurring as a result of the impact of COVID-19 on the HIV pandemic.

General Pulmonology

Cancer Patients Respond Well to COVID-19 Vaccine

Estie Mermelstein, MSN, FNP-BC

June 30, 2021

Investigators evaluated antibody response to the Pfizer BioNTech COVID-19 vaccine in patients actively undergoing treatment for cancer.

Lung Infection

Moderna, Pfizer-BioNTech COVID-19 Vaccines Provide Immunity in Pregnant Women

Estie Mermelstein, MSN, FNP-BC

June 23, 2021

Investigators assessed response to vaccination with the Moderna or Pfizer-BioNTech COVID-19 vaccines in pregnant and nonpregnant lactating women.

Pneumonia

Patients With CAP at Increased Risk for CV Events and Poor Clinical Outcomes

Estie Mermelstein, MSN, FNP-BC

April 19, 2021

Investigators assessed the cumulative incidence of acute cardiovascular complications during hospitalization for community-acquired pneumonia in internal medicine units.

Lung Infection

Umifenovir Contributes to Clinical and Laboratory Improvement of COVID-19 Management

Estie Mermelstein, MSN, FNP-BC

February 12, 2021

A randomized controlled trial was conducted to evaluate the efficacy of umifenovir as a monotherapy for the hospitalized patients with COVID-19.

Lung Infection

WHO: Remdesivir, Hydroxychloroquine, Lopinavir, Interferon Ineffective for COVID-19

Estie Mermelstein, MSN, FNP-BC

February 4, 2021

World Health Organization expert provided data on 4 repurposed antiviral drugs – remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a – and its use in patients hospitalized with COVID-19.

Lung Infection

Systemic Analysis of the Hallmarks of Advanced COVID-19 Pathology

Estie Mermelstein, MSN, FNP-BC

December 14, 2020

Study authors provided a systemic analysis of to identify key characteristics of extensive and advanced COVID-19.

Next post in Lung Infection